Related references
Note: Only part of the references are listed.The Molecular Mechanism of Action of Artemisinin-The Debate Continues
Paul M. O'Neill et al.
MOLECULES (2010)
Dihydroartemisinin inhibits growth of pancreatic cancer cells in vitro and in vivo
Hua Chen et al.
ANTI-CANCER DRUGS (2009)
Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1α and P-glycoprotein overexpression
C. Riganti et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Pomalidomide and Lenalidomide Induce p21WAF-1 Expression in Both Lymphoma and Multiple Myeloma through a LSD1-Mediated Epigenetic Mechanism
Laure Escoubet-Lozach et al.
CANCER RESEARCH (2009)
Artemisinin reduces human melanoma cell migration by down-regulating αVβ3 integrin and reducing metalloproteinase 2 production
Elisabetta Buommino et al.
INVESTIGATIONAL NEW DRUGS (2009)
Artemisinin Blocks Prostate Cancer Growth and Cell Cycle Progression by Disrupting Sp1 Interactions with the Cyclin-dependent Kinase-4 (CDK4) Promoter and Inhibiting CDK4 Gene Expression
Jamin A. Willoughby et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Dihydroartemisinin induces apoptosis and sensitizes human ovarian cancer cells to carboplatin therapy
Tao Chen et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Dihydroartemisinin induces apoptosis in human leukemia cells HL60 via downregulation of transferrin receptor expression
Hui-Jun Zhou et al.
ANTI-CANCER DRUGS (2008)
First assessment in humans of the safety, tolerability, pharmacokinetics, and ex vivo pharmacodynamic antimalarial activity of the new artemisinin derivative artemisone
Johannes Nagelschmitz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Experimental therapy of hepatoma with artemisinin and its derivatives:: In vitro and in vivo activity, chemosensitization, and mechanisms of action
Junmei Hou et al.
CLINICAL CANCER RESEARCH (2008)
Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation
Ikuhiko Nakase et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Enhancing the in vitro cytotoxic activity of Delta(9)-tetrahydrocannabinol in leukemic cells through a combinatorial approach
Wai M. Liu et al.
LEUKEMIA & LYMPHOMA (2008)
Artemisinins: their growing importance in medicine
Sanjeev Krishna et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
Enhancing the Cytotoxic Activity of Novel Targeted Therapies - Is There a Role for a Combinatorial Approach?
Wai Man Liu
CURRENT CLINICAL PHARMACOLOGY (2008)
Artesunate attenuates the growth of human colorectal carcinoma and inhibits hyperactive Wnt/β-catenin pathway
Lin-Na Li et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Antimalarial efficacy and drug interactions of the novel semi-synthetic endoperoxide artemisone in vitro and in vivo
L. Vivas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Case report of a pituitary macroadenoma treated with artemether
Narendra P. Singh et al.
INTEGRATIVE CANCER THERAPIES (2006)
Current perspectives on the mechanism of action of artemisinins
Jacob Golenser et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2006)
Unscheduled CDK1 activity in G1 phase of the cell cycle triggers apoptosis in X-irradiated lymphocytic leukemia cells
J. Wu et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Artemisone - A highly active antimalarial drug of the artemisinin class
RK Haynes et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2006)
Role of p21waf1/cip1 in effects of oxaliplatin in colorectal cancer cells
T Hata et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Antimalarial dihydroartemisinin also inhibits angiogenesis
HH Chen et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2004)
Artemisinin derivatives: toxic for laboratory animals, safe for humans?
T Gordi et al.
TOXICOLOGY LETTERS (2004)
Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro
HH Chen et al.
PHARMACOLOGICAL RESEARCH (2003)
Molecular modes of action of artesunate in tumor cell lines
T Efferth et al.
MOLECULAR PHARMACOLOGY (2003)
The antimalaria agent artemisinin exerts antiangiogenic effects in mouse embryonic stem cell-derived embryoid bodies
M Wartenberg et al.
LABORATORY INVESTIGATION (2003)
Novel antitumor artemisinin derivatives targeting G1 phase of the cell cycle
Y Li et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
Share Paper
